KREBSBIO Share Price Target 2050

CAGR-based price projection for Krebs Biochemicals and Industries Limited (KREBSBIO) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (4.0% CAGR)
Rs 175
2050 Target
Base Case (10.0% CAGR)
Rs 676
2050 Target
Bull Case (27.4% CAGR)
Rs 22,832
2050 Target

Current Market Snapshot

CMP: Rs 68.05
52W High: Rs 68.14
52W Low: Rs 51.90
1Y CAGR: 21.1%
3Y CAGR: 10.0%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 71 Rs 75 Rs 87
2028 Rs 74 Rs 82 Rs 110
2029 Rs 77 Rs 91 Rs 141
2030 Rs 80 Rs 100 Rs 179
2031 Rs 83 Rs 110 Rs 229
2032 Rs 86 Rs 121 Rs 291
2033 Rs 90 Rs 133 Rs 371
2034 Rs 93 Rs 146 Rs 473
2035 Rs 97 Rs 161 Rs 603
2036 Rs 101 Rs 177 Rs 768
2037 Rs 105 Rs 195 Rs 978
2038 Rs 109 Rs 215 Rs 1,246
2039 Rs 114 Rs 236 Rs 1,588
2040 Rs 118 Rs 260 Rs 2,024
2041 Rs 123 Rs 286 Rs 2,579
2042 Rs 128 Rs 315 Rs 3,286
2043 Rs 133 Rs 346 Rs 4,187
2044 Rs 138 Rs 381 Rs 5,335
2045 Rs 144 Rs 419 Rs 6,798
2046 Rs 150 Rs 461 Rs 8,662
2047 Rs 156 Rs 508 Rs 11,037
2048 Rs 162 Rs 559 Rs 14,063
2049 Rs 168 Rs 615 Rs 17,919
2050 Rs 175 Rs 676 Rs 22,832

Other KREBSBIO Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the KREBSBIO share price target for 2050?

Based on historical growth analysis, the KREBSBIO share price target for 2050 ranges from Rs 175 (conservative) to Rs 676 (base case) to Rs 22,832 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of KREBSBIO?

The current market price of KREBSBIO (Krebs Biochemicals and Industries Limited) is Rs 68.05. The 52-week high is Rs 68.14 and 52-week low is Rs 51.90.

Is KREBSBIO a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for KREBSBIO price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 4.0% CAGR), Base (10.0% CAGR), and Bull (optimistic at 27.4% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.